Showing results (71-80 of 82) with videos related to
Sort By:
Pageof 9
Nature Communications|January 31, 2024
Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial, Peter W Horby, Leon Peto, et al.JAMA|November 7, 2025
SGLT2 Inhibitors and Kidney Outcomes by Glomerular Filtration Rate and Albuminuria: A Meta-AnalysisBrendon L Neuen, Robert A Fletcher, Stefan D Anker, et al.The Lancet. Diabetes & Endocrinology|July 11, 2024
Efficacy and safety of SGLT2 inhibitors with and without glucagon-like peptide 1 receptor agonists: a SMART-C collaborative meta-analysis of randomised controlled trialsEllen M Apperloo, Brendon L Neuen, Robert A Fletcher, et al.Circulation|April 7, 2024
Sodium-Glucose Cotransporter-2 Inhibitors and Major Adverse Cardiovascular Outcomes: A SMART-C Collaborative Meta-AnalysisSiddharth M Patel, Yu Mi Kang, KyungAh Im, et al.British Journal of Cancer|September 6, 2025
Chronic kidney disease and incident cancer risk: an individual participant data meta-analysisYejin Mok, Aditya Surapaneni, Yingying Sang, et al.The New England Journal of Medicine|November 4, 2022
Empagliflozin in Patients with Chronic Kidney Disease, William G Herrington, Natalie Staplin, et al.The New England Journal of Medicine|October 25, 2024
Long-Term Effects of Empagliflozin in Patients with Chronic Kidney Disease, William G Herrington, Natalie Staplin, et al.Diabetes Care|July 20, 2022
Development and Validation of Prediction Models of Adverse Kidney Outcomes in the Population With and Without DiabetesMorgan E Grams, Nigel J Brunskill, Shoshana H Ballew, et al.Journal of the American Society of Nephrology : JASN|March 1, 2023
The Kidney Failure Risk Equation: Evaluation of Novel Input Variables including eGFR Estimated Using the CKD-EPI 2021 Equation in 59 CohortsMorgan E Grams, Nigel J Brunskill, Shoshana H Ballew, et al.Nature Medicine|May 5, 2026
Multinational validation of the PREVENT and SCORE2 cardiovascular risk equations across 6.4 million individualsBrendon L Neuen, Rupert W Major, Morgan E Grams, et al.Pageof 9